These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29351298)

  • 21. Development of a High-Content Orthopoxvirus Infectivity and Neutralization Assays.
    Gates I; Olson V; Smith S; Patel N; Damon I; Karem K
    PLoS One; 2015; 10(10):e0138836. PubMed ID: 26426117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
    Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
    Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine.
    Wu JQ; Barabé ND; Chau D; Wong C; Rayner GR; Hu WG; Nagata LP
    Vaccine; 2007 May; 25(22):4368-75. PubMed ID: 17467858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
    Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
    Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication.
    Hagen CJ; Titong A; Sarnoski EA; Verardi PH
    Virus Res; 2014 Mar; 181():43-52. PubMed ID: 24394294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy.
    Pletnev AG; Putnak R; Speicher J; Wagar EJ; Vaughn DW
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3036-41. PubMed ID: 11880643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant.
    Reeman S; Gates AJ; Pulford DJ; Krieg A; Ulaeto DO
    Viruses; 2017 Dec; 9(12):. PubMed ID: 29232844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the contribution of CTL epitopes in the immunobiology of morbillivirus infection.
    Beauverger P; Cardoso AI; Daviet L; Buckland R; Wild TF
    Virology; 1996 May; 219(1):133-9. PubMed ID: 8623522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic Variability of Myxoma Virus Genomes.
    Braun C; Thürmer A; Daniel R; Schultz AK; Bulla I; Schirrmeier H; Mayer D; Neubert A; Czerny CP
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. African Swine Fever Virus Georgia Isolate Harboring Deletions of MGF360 and MGF505 Genes Is Attenuated in Swine and Confers Protection against Challenge with Virulent Parental Virus.
    O'Donnell V; Holinka LG; Gladue DP; Sanford B; Krug PW; Lu X; Arzt J; Reese B; Carrillo C; Risatti GR; Borca MV
    J Virol; 2015 Jun; 89(11):6048-56. PubMed ID: 25810553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poxvirus Safety Analysis in the Pregnant Mouse Model, Vaccinia, and Raccoonpox Viruses.
    Roper RL
    Methods Mol Biol; 2017; 1581():121-129. PubMed ID: 28374246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Host Restriction Factor Interferon-Inducible Transmembrane Protein 3 Inhibits Vaccinia Virus Infection.
    Li C; Du S; Tian M; Wang Y; Bai J; Tan P; Liu W; Yin R; Wang M; Jiang Y; Li Y; Zhu N; Zhu Y; Li T; Wu S; Jin N; He F
    Front Immunol; 2018; 9():228. PubMed ID: 29503647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library.
    Shin YW; Chang KH; Hong GW; Yeo SG; Jee Y; Kim JH; Oh MD; Cho DH; Kim SH
    J Microbiol Biotechnol; 2019 Apr; 29(4):651-657. PubMed ID: 30856707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.
    Ly HJ; Nishiyama S; Lokugamage N; Smith JK; Zhang L; Perez D; Juelich TL; Freiberg AN; Ikegami T
    Vaccine; 2017 Dec; 35(48 Pt B):6634-6642. PubMed ID: 29061350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenic and protective properties of haemagglutinin protein (H) of rinderpest virus expressed by a recombinant baculovirus.
    Naik S; Renukaradhya GJ; Rajasekhar M; Shaila MS
    Vaccine; 1997; 15(6-7):603-7. PubMed ID: 9178457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines.
    Welter J; Taylor J; Tartaglia J; Paoletti E; Stephensen CB
    J Virol; 2000 Jul; 74(14):6358-67. PubMed ID: 10864646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model.
    Wyatt LS; Shors ST; Murphy BR; Moss B
    Vaccine; 1996 Oct; 14(15):1451-8. PubMed ID: 8994321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges.
    Fogg CN; Americo JL; Lustig S; Huggins JW; Smith SK; Damon I; Resch W; Earl PL; Klinman DM; Moss B
    Vaccine; 2007 Apr; 25(15):2787-99. PubMed ID: 17229505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.